Periprocedural adverse events after revascularisation: the importance of getting off to a good start

EuroIntervention 2023;18:1220-1221. DOI: 10.4244/EIJ-E-22-00054

Mario Gaudino
Mario Gaudino1, MD, PhD; Arnaldo Dimagli1, MD
1. Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY, USA
In this issue of the journal, Kotoky et al shed light on the association between periprocedural major adverse events (PMAE) and long-term mortality in patients undergoing coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) in a post hoc analysis of the SYNTAX trial1. The authors should be congratulated for this important work and the food for thought it provides. PMAE were defined as a composite of numerous periprocedural complications occurring within 30 days from the index procedure. Patients undergoing CABG were more likely to experience one of these events than those undergoing PCI (28.2% vs 11.2%; p<0.001). ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Transcatheter mitral valve replacement will remain a niche therapy: pros and cons

Latest news